Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TMT-Based Quantitative Proteomics Analysis Reveals Differentially Expressed Proteins between Different Sources of hMSCs. | Int J Mol Sci | 2023 | 37686351 | PubTator, text mining | PubMed |
| Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer. | Front Oncol | 2023 | 37681030 | PubTator, text mining | PubMed |
| Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation. | Aging (Albany NY) | 2023 | 37671970 | PubTator, text mining | PubMed |
| Time-resolved quantitative proteomic analysis of the developing Xenopus otic vesicle reveals putative congenital hearing loss candidates. | iScience | 2023 | 37670778 | PubTator, text mining | PubMed |
| Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma. | Nat Commun | 2023 | 37669956 | PubTator, text mining | PubMed |
| CHD7 variants associated with hearing loss and enlargement of the vestibular aqueduct. | Hum Genet | 2023 | 37668839 | PubTator, text mining | PubMed |
| Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2. | Stem Cell Res Ther | 2023 | 37667335 | PubTator, text mining | PubMed |
| Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | 37666813 | PubTator, text mining | PubMed |
| Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis. | J Neurooncol | 2023 | 37656377 | PubTator, text mining | PubMed |
| Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 - metastatic or advanced breast cancer patients: a network meta-analysis. | BMC Cancer | 2023 | 37653504 | PubTator, text mining | PubMed |
| Intercellular cross-talk through lineage-specific gap junction of cancer-associated fibroblasts related to stromal fibrosis and prognosis. | Sci Rep | 2023 | 37648762 | PubTator, text mining | PubMed |
| Fibroblasts - the cellular choreographers of wound healing. | Front Immunol | 2023 | 37646029 | PubTator, text mining | PubMed |
| Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors. | Breast Cancer Res | 2023 | 37644609 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Altered Proteomic Profile of Exosomes Secreted from Vero Cells Infected with Porcine Epidemic Diarrhea Virus. | Viruses | 2023 | 37631983 | PubTator, text mining | PubMed |
| The Association of Novel Single-Nucleotide Variants in the Collagen Matrix-Encoding Gene PRDM5 with Aortic Aneurysmal Disease. | Life (Basel) | 2023 | 37629506 | PubTator, text mining | PubMed |
| Insights from a Computational-Based Approach for Analyzing Autophagy Genes across Human Cancers. | Genes (Basel) | 2023 | 37628602 | PubTator, text mining | PubMed |
| Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy. | Cancers (Basel) | 2023 | 37627219 | PubTator, text mining | PubMed |
| Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions. | Cells | 2023 | 37626881 | PubTator, text mining | PubMed |
| Novel CAF-identifiers via transcriptomic and protein level analysis in HNSC patients. | Sci Rep | 2023 | 37626157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=17